poisar

Stock

Abbott Laboratories ABT

$108.79-1.51%

Overview

ABT market data

Price History

ABT price chart · 1M
O
110.97
H
111.96
L
108.09
C
108.79
Vol
215,257.00
Source
US equities market feed
Observed
Sep 3, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$110.97
Previous Close
$110.46
Day High
$111.96
Day Low
$108.09
52 Week High
$117.32
52 Week Low
$81.39
7 Day Return
-2.48%
30 Day Return
+3.14%
90 Day Return
+20.32%
1 Year Return
+26.00%
Daily Notional Volume
$23.4M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
35.52
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$3.73
Diluted earnings per share over the trailing twelve months.
Beta
0.54
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
2.0%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
11.7%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$81.97 – $137.49
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $192.7B · P/B 4.18 · P/S 4.14.

Company News

10 captured
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term PortfolioThe Motley Fool · Sep 2, 2026, 7:15 PM
National Advertising Division Finds Certain Kendamil Infant Formula Claims Supported; Recommends Others Be Modified or DiscontinuedGlobenewswire Inc · Aug 31, 2026, 2:15 PM
Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035Globenewswire Inc · Aug 31, 2026, 11:00 AM
Abbott (ABT) Stock Sinks As Market Gains: Here's WhyZacks Investment Research · Aug 27, 2026, 11:15 PM
Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsightGlobenewswire Inc · Aug 27, 2026, 5:30 PM
Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS InsiderGlobenewswire Inc · Aug 27, 2026, 3:15 PM
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingBenzinga · Aug 26, 2026, 1:36 PM
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and MedtronicGlobenewswire Inc · Aug 26, 2026, 12:15 PM
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.The Motley Fool · Aug 26, 2026, 11:15 AM
FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And KetonesBenzinga · Aug 25, 2026, 6:35 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock